Drugwatch reveals how the legal system steps in when drug safety fails. Hosts Terry Turner and Whitney Ray Di Bona investigate new lawsuits over rare, permanent vision loss tied to GLP‑1 drugs like Ozempic and Wegovy. This discovery uncovers a wider trend — drugs approved on limited evidence, safety risks surfacing only after millions of prescriptions and families seeking answers in court.
Stanford law professor Nora Freeman Engstrom highlights how opioid litigation forced open the DEA's secret ARCOS database, which she calls the "Rosetta Stone" of the opioid crisis. Whistleblower advocate Louis Clark and former Merck insider William Soliman explain how Vioxx stayed on the market despite heart‑risk warnings.
Through these stories, this episode showcases how lawsuits can serve as a shadow regulator for Big Pharma, exposing hidden data, reshaping public understanding, and sometimes, finally removing dangerous drugs from the shelves.
You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties on Drugwatch.com
Podden och tillhörande omslagsbild på den här sidan tillhör
Drugwatch.com. Innehållet i podden är skapat av Drugwatch.com och inte av,
eller tillsammans med, Poddtoppen.
